This year's recipient of the Blue Faery Award is Dr. Mark Feitelson, Professor of Biology at Temple University and Associate Director of the Temple Biotechnology Center. His research focuses on understanding the biology of hepatitis B and hepatitis C and how they lead to the development of chronic liver diseases including liver cancer. The author of two books, Dr. Feitelson has over 100 publications in highly ranked international scientific journals. He has also delivered more than 160 oral presentations/posters at national and international meetings and more than 100 lectureships across the world. In 2005, Dr. Feitelson distributed Blue Faery's HCC Chinese Patient Education Brochures in four treatment centers in China.
Andrea Wilson started Blue Faery in honor of her sister, Adrienne, who died of HCC only 145 days after her diagnosis at the age of 15. Blue Faery announces the recipient of the BFA on April 8, 2013 -- Adrienne's birthday. She would have been 27 years old this year. Dr. Feitelson will receive $3,000 toward his research to commemorate his achievement. The non-profit organization's goal is to increase the award amount in subsequent years.
Founded in 2002, Blue Faery is the only nonprofit organization in the United States solely devoted to fighting HCC. The mission of Blue Faery is to prevent, treat and cure primary liver cancer, specifically hepatocellular carcinoma, through research, education and advocacy. Blue Faery has developed an HCC patient education brochure for liver cancer patients, their families and their healthcare providers. The FREE brochure, which has been translated into Chinese and Spanish, has been distributed in 30 treatment centers across the nation.
For more information on how to apply for the BFA, visit the Blue Faery Award page on Blue Faery's Web site www.bluefaery.org. To learn more about liver cancer, sign up for the Blue Faery quarterly e-newsletter. You can also call Andrea Wilson at 818-636-5624 or email her at email@example.com.